MetaCap

Insulet Earnings

NASDAQ: PODDHealth CareMedical/Dental InstrumentsUSD

134.47+0.11 (+0.08%)

At close: Oct 8, 4:00 PM ET · Delayed 15 min

Next earnings date

Wed, Nov 4, 2026

Before market open

Fiscal period

Sep/2026

EPS estimate

$1.59

Insulet earnings summary

Insulet is scheduled to report Sep/2026 earnings on Nov 4, 2026 before the market opens, with analysts expecting EPS of $1.59. In its most recent report on Aug 5, 2026 (Q2 2026), PODD posted EPS of $1.37. Revenue for the quarter was $801.7 million.

Quarterly EPS is up 328.1% from the same quarter a year earlier. Across the last 16 reports, PODD shares moved an average of 4.8% (in either direction) in the first trading session after results, rising 8 times and falling 8 times.

Summary generated from market data by MetaCap's automated system. Methodology

PODD earnings history

Insulet reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Aug 5, 2026—$1.37—+1.5%
May 6, 2026—$1.30—-4.3%
Feb 18, 2026—$1.42—+2.0%
Nov 6, 2025—$1.24—+4.0%
Aug 7, 2025—$0.32—+4.6%
May 9, 2025—$0.50—+4.5%
Feb 21, 2025—$1.38—-3.7%
Nov 8, 2024—$1.08—-2.9%
Aug 9, 2024—$2.59—+6.2%
May 10, 2024—$0.73—+12.9%
Feb 23, 2024—$1.47—-8.1%
Nov 3, 2023—$0.74—-4.6%
Aug 9, 2023—$0.39—-9.0%
May 5, 2023—$0.34—+0.4%
Feb 24, 2023—$0.25—-2.4%
Nov 4, 2022—$-0.08—-6.2%

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related